Gene therapy injection aims to cure radiation dry mouth
Disease control
Recruiting now
This early-stage trial tests a new treatment called RXRG001 for people with long-term dry mouth and low saliva after radiation therapy for cancer. The treatment is a genetic material delivered directly into the saliva glands to help them produce more fluid. The study involves 42 …
Phase: PHASE1, PHASE2 • Sponsor: RiboX Therapeutics Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC